Severe traumatic brain injury: targeted management in the Intensive Care Unit
The Lancet Publishing Group
MetadataShow full item record
Stocchetti, N., Carbonara, M., Citerio, G., Ercole, A., Skrifvars, M., Smielewski, P., Zoerle, T., & et al. (2017). Severe traumatic brain injury: targeted management in the Intensive Care Unit. Lancet Neurology, 16 (6), 452-464. https://doi.org/10.1016/S1474-4422(17)30118-7
Severe traumatic brain injury (TBI) is currently managed in the intensive care unit with a combined medical– surgical approach. Treatment aims to prevent additional brain damage and to optimise conditions for brain recovery. TBI is typically considered and treated as one pathological entity, although in fact it is a syndrome comprising a range of lesions that can require di erent therapies and physiological goals. Owing to advances in monitoring and imaging, there is now the potential to identify speci c mechanisms of brain damage and to better target treatment to individuals or subsets of patients. Targeted treatment is especially relevant for elderly people—who now represent an increasing proportion of patients with TBI—as preinjury comorbidities and their therapies demand tailored management strategies. Progress in monitoring and in understanding pathophysiological mechanisms of TBI could change current management in the intensive care unit, enabling targeted interventions that could ultimately improve outcomes.
MBS reports grants from Helsinki University, Finland, Finska Lakaresallskapet, Svenska Kulturfonden, and Stiftelsen för Perklens Minne during the preparation of this review. DKM reports grants from the European Union (FP7 grant for the CENTER-TBI study) and support from the National Institute for Healthcare Research, UK, during the preparation of this review.
EC FP7 CP (602150)
External DOI: https://doi.org/10.1016/S1474-4422(17)30118-7
This record's URL: https://www.repository.cam.ac.uk/handle/1810/264446